Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse
Background. Tafenoquine is an 8-aminoquinoline developed as a more effective replacement for primaquine. In a previous dose-ranging study in Thailand, 3 tafenoquine regimens with total doses ranging from 500 mg to 3000 mg prevented relapse of Plasmodium vivax malaria in most patients when administer...
Saved in:
Main Authors: | Douglas S. Walsh, Polrat Wilairatana, Douglas B. Tang, D. Gray Heppner, Thomas G. Brewer, Srivicha Krudsood, Udomsak Silachamroon, Weerapong Phumratanaprapin, Duangsuda Siriyanonda, Sornchai Looareesuwan |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/21353 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
by: Douglas S. Walsh, et al.
Published: (2018) -
Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of plasmodium vivax in Thailand
by: Narong Ponsa, et al.
Published: (2018) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria
by: Srivicha Krudsood, et al.
Published: (2018) -
Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria
by: Marcus V.G. Lacerda, et al.
Published: (2020) -
Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
by: Alejandro Llanos-Cuentas, et al.
Published: (2020)